Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SOPHiA GENETICS SA SOPH

Healthcare Medical Devices
Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and... see more

Recent & Breaking News (NDAQ:SOPH)

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

PR Newswire May 29, 2024

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

PR Newswire May 20, 2024

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

PR Newswire May 16, 2024

SOPHiA GENETICS Reports First Quarter 2024 Results

GlobeNewswire May 7, 2024

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

GlobeNewswire April 30, 2024

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

GlobeNewswire April 23, 2024

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

PR Newswire April 23, 2024

SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)

PR Newswire April 17, 2024

SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership

PR Newswire April 4, 2024

Laboratorio Barnafi-Krause is Live on SOPHiA DDM(TM)

PR Newswire April 2, 2024

SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada

PR Newswire March 20, 2024

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

PR Newswire March 15, 2024

SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference

GlobeNewswire March 7, 2024

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results

GlobeNewswire March 5, 2024

SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care Conference

GlobeNewswire February 22, 2024

SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024

GlobeNewswire February 20, 2024

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

PR Newswire February 7, 2024

SOPHiA GENETICS Supports Genetic Testing in Brazil

PR Newswire January 25, 2024

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

PR Newswire January 18, 2024

SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India

PR Newswire January 14, 2024